Over 1.5 million preventable new hepatitis B infections continue to occur each year and
there are an estimated 296 million people living with chronic hepatitis B infection worldwide …

Virus-like particles (VLPs) are self-assembled structures derived from viral antigens that
mimic the native architecture of viruses but lack the viral genome. VLPs have emerged as a …

After several decades of vaccination against hepatitis B virus in newborns, infants,
adolescents, and adults, the question remains whether a booster dose is ever needed. Long …

The liver is endowed with an amazing regenerative capacity that allows it to withstand an
enormous amount of damage. Nevertheless, it is precisely this highly regenerative capacity …

The long-term efficacy of hepatitis B vaccine, long-term effectiveness of hepatitis B
immunisation programmes, immune memory induced by hepatitis B vaccine, current booster …

Accurate prognosis prediction in oncology is critical. In patients with hepatocellular
carcinoma (HCC), unlike most solid tumors, the coexistence of two life-threatening …

Abstract The International Agency for Research on Cancer (IARC) has comprehensively
assessed the human carcinogenicity of biological agents. Seven viruses including Epstein …

We conducted a systematic review of the published literature to examine the impact of new
vaccine introduction on countries' immunization and broader health systems. Six publication …

A population-based hepatitis survey was carried out to estimate the prevalence of hepatitis B
virus (HBV) infection and its predictive factors for the state capitals from the north, south, and …

The development of hepatocellular carcinoma (HCC), the mechanisms of
hepatocarcinogenesis, the prevention of HCC, and screening for HCC will be discussed …